Sewanti Limaye
0000-0002-2170-5187
2 papers found
Refreshing results…
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2–Activating Mutations: Results From the National Cancer Institute–Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-B
Oral mucositis—case series of a rare adverse effect associated with immunotherapy
Missing publications? Search for publications with a matching author name.